Download Files:
Datopotamab deruxtecan
$1,280 – $3,800
Products Details
Product Description
– Datopotamab deruxtecan (DS-1062; Dato-DXd) is a trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan has a potent antitumor activity[1].
Web ID
– HY-141598
Storage Temperature
– -80°C, protect from light
Shipping
– Dry Ice
Applications
– Cancer-programmed cell death
Molecular Formula
– N/A
References
– [1]Daisuke Okajima, et al. Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells. Mol Cancer Ther. 2021 Aug 19.
CAS Number
– 2238831-60-0
Molecular Weight
– N/A
Compound Purity
– 99.54
SMILES
– [Datopotamab deruxtecan]
Clinical Information
– Phase 3
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Antibody-Drug Conjugates (ADCs);Topoisomerase
Isoform
– Topo I
Pathway
– Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage
Product type
– ADC Related
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
